Takumi Hirata1, Yasumichi Arai1, Michiyo Takayama2, Yukiko Abe1, Kiyoshi Ohkuma3, Toru Takebayashi4. 1. Center for Supercentenarian Medical Research, Keio University School of Medicine. 2. Center for Preventive Medicine, Keio University School of Medicine. 3. Department of Radiology, Keio University School of Medicine. 4. Department of Preventative Medicine and Public Health, Keio University School of Medicine.
Abstract
AIM: Accumulating evidence suggests that predictability of traditional cardiovascular risk factors declines with advancing age. We investigated whether carotid plaque scores (CPSs) were associated with cardiovascular disease (CVD) death in the oldest old, and whether asymmetrical dimethylarginine (ADMA), a marker of endothelial dysfunction, moderated the association between the CPS and CVD death. METHODS: We conducted a prospective cohort study of Japanese subjects aged ≥85 years without CVD at baseline. We followed this cohort for 6 years to investigate the association of CPS with CVD death via multivariable Cox proportional hazard analysis. We divided participants into three groups according to CPS (no, 0 points; low, 1.2-4.9 points; high, ≥5.0 points). The predictive value of CPS for estimating CVD death risk over CVD risk factors, including ADMA, was examined using C-statistics. RESULTS: We analyzed 347 participants (151 men, 196 women; mean age, 87.6 years), of which 135 (38.9%) had no carotid plaque at baseline, and 48 (13.8%) had high CPS. Of the total, 29 (8.4%) participants experienced CVD-related death during the study period. Multivariable analysis revealed a significant association of high CPS with CVD-related mortality relative to no CPS (hazard ratio, 3.90; 95% confidence interval: 1.47-10.39). ADMA was not associated with CVD death, but the significant association between CPS and CVD death was observed only in lower ADMA level. The addition of CPS to other risk factors improved the predictability of CVD death (p=0.032). CONCLUSIONS: High CPS correlated significantly with a higher CVD death risk in the oldest old with low cardiovascular risk. Ultrasound carotid plaque evaluation might facilitate risk evaluations of CVD death in the very old.
AIM: Accumulating evidence suggests that predictability of traditional cardiovascular risk factors declines with advancing age. We investigated whether carotid plaque scores (CPSs) were associated with cardiovascular disease (CVD) death in the oldest old, and whether asymmetrical dimethylarginine (ADMA), a marker of endothelial dysfunction, moderated the association between the CPS and CVD death. METHODS: We conducted a prospective cohort study of Japanese subjects aged ≥85 years without CVD at baseline. We followed this cohort for 6 years to investigate the association of CPS with CVD death via multivariable Cox proportional hazard analysis. We divided participants into three groups according to CPS (no, 0 points; low, 1.2-4.9 points; high, ≥5.0 points). The predictive value of CPS for estimating CVD death risk over CVD risk factors, including ADMA, was examined using C-statistics. RESULTS: We analyzed 347 participants (151 men, 196 women; mean age, 87.6 years), of which 135 (38.9%) had no carotid plaque at baseline, and 48 (13.8%) had high CPS. Of the total, 29 (8.4%) participants experienced CVD-related death during the study period. Multivariable analysis revealed a significant association of high CPS with CVD-related mortality relative to no CPS (hazard ratio, 3.90; 95% confidence interval: 1.47-10.39). ADMA was not associated with CVD death, but the significant association between CPS and CVD death was observed only in lower ADMA level. The addition of CPS to other risk factors improved the predictability of CVD death (p=0.032). CONCLUSIONS: High CPS correlated significantly with a higher CVD death risk in the oldest old with low cardiovascular risk. Ultrasound carotid plaque evaluation might facilitate risk evaluations of CVD death in the very old.
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Maria Lajer; Lise Tarnow; Anders Jorsal; Tom Teerlink; Hans-Henrik Parving; Peter Rossing Journal: Diabetes Care Date: 2007-12-27 Impact factor: 19.112
Authors: Tao Zhou; Xia Li; Zhe Tang; Changchun Xie; Lixin Tao; Lei Pan; Da Huo; Fei Sun; Yanxia Luo; Wei Wang; Aoshuang Yan; Xiuhua Guo Journal: Int J Environ Res Public Health Date: 2014-02-21 Impact factor: 3.390
Authors: Ankush Jamthikar; Deep Gupta; Narendra N Khanna; Tadashi Araki; Luca Saba; Andrew Nicolaides; Aditya Sharma; Tomaz Omerzu; Harman S Suri; Ajay Gupta; Sophie Mavrogeni; Monika Turk; John R Laird; Athanasios Protogerou; Petros P Sfikakis; George D Kitas; Vijay Viswanathan; Gyan Pareek; Martin Miner; Jasjit S Suri Journal: Curr Atheroscler Rep Date: 2019-05-01 Impact factor: 5.113
Authors: Ankush Jamthikar; Deep Gupta; Narendra N Khanna; Luca Saba; Tadashi Araki; Klaudija Viskovic; Harman S Suri; Ajay Gupta; Sophie Mavrogeni; Monika Turk; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; George D Kitas; Vijay Viswanathan; Andrew Nicolaides; Deepak L Bhatt; Jasjit S Suri Journal: Cardiovasc Diagn Ther Date: 2019-10